+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)

  • PDF Icon

    Report

  • 71 Pages
  • October 2023
  • Region: Global
  • Kalorama Information
  • ID: 5779150


In vitro diagnostics is a global market estimated to consist of over $120 billion. With less than half that revenue earned in the United States, an assessment of regional and country IVD markets is needed for successful business planning.  Kalorama’s 30 Country IVD Market Atlas report is designed to provide you with international market detail at the country-level to help improve your forecast modeling and planning.

Whether you need Latin America, Middle East, APAC or Eastern Europe, this report has country-level markets and forecasts.

If you need geographical IVD markets by country from an authoritative source, this report also provides that. Up to date as of Q3 2023, this report is designed to cover every significant world IVD market.

  • One Report Covering 30 Countries
  • Reliable Estimates From an IVD-Focused Analyst Team  (The Authors of Kalorama’s Worldwide Market for In Vitro Diagnostics)
  • Sizing for 19 Important IVD Market Segments
  • Segments Estimated for Each Country
  • Lab-Based and POC Segments for Many Disease Areas
  • Designed to Align with Other Kalorama Reports
  • Forecasts in Revenue to 2028 for Each Segment
  • CAGRS for Each Segment and Country
  • Updated Quarterly (4 updates annually) to Reflect Market Changes
  • Analyst Notes for Significant Developments
  • Definitions and Descriptions of Tests
  • Over 2800 Data Points

Over two decades of publishing in vitro diagnostic market research, Kalorama Information has heard from customers: IVD is a global industry, growth is global and our customers want more geographic coverage.  As a result, we are offering geographic research and analysis focused at the country, rather than regional level in our 30 Country In Vitro Diagnostics (IVD) Market Atlas.  A quarterly-updated, 30-country market research report with the major IVD segments forecasted out five years.

To replicate the 2800+ data points in the IVD Market Atlas, you’d need to buy dozens of other company's market research studies.

This quarterly updated report contains IVD markets aligned to Kalorama’s expert global estimates in our Worldwide Market for In Vitro Diagnostics, segmented for 30 important country markets and for 19 key test segments.

Countries covered in the IVD Market Atlas include:

  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • China
  • Egypt
  • France
  • Germany
  • India
  • Indonesia
  • Italy
  • Japan
  • Mexico
  • Netherlands
  • Poland
  • Romania
  • Russia
  • Saudi Arabia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
  • United States
  • Vietnam

Market researchers will tend to sell reports for each of these countries, rather than combine in one report.  For Kalorama, our mission is different.  The analyst seeks to keep companies informed with useful references when they need it, rather than publish hundreds of reports a year. The IVD Market Atlas reflects this mission. 

It’s important to note that for each of these countries, there is an overall IVD market estimate and then, the most important market segments are broken out. These include:

  • Blood Bank Immunoassays
  • Blood Bank Molecular (NAT)
  • Clinical Chemistry
  • Coagulation
  • COVID-19
  • Critical Care
  • FOB
  • Glucose
  • Hematology
  • Histology/Cytology
  • ID/AST Microbiology
  • Immunoassays
  • Immunoassays, Micro
  • Molecular, Micro
  • Molecular, Others
  • Overall Country IVD
  • Point of Care
  • POC Infectious Disease
  • Pregnancy Testing

While these are not every segment possible, they are the most important [most searched for/requested and largest] IVD market segments.

The report is updated every 3 months.  Why?  This is to keep up with market changes.  It was once the case that the IVD market didn’t change rapidly.  COVID-19, international changes, M&A activity, new products, point of care trends and regulatory activity have all worked together to change that.  While there may not be substantial change in markets between one quarter and another, the report will catch segment changes, and you will always have an updated data set for your business planning.

Those who subscribe will be placed on our Knowledge Center product and will receive quarterly updates.

Table of Contents

Chapter One: Worldwide IVD Market
  • IVD Market Demand and Growth
  • Scope and Methodology
  • Market Segmentation
  • Country Atlas Scope
  • Table 1-1: Key Interest Countries (30-Country Atlas) for IVD Markets, 2023
Chapter Two: United States
  • U.S. IVD Market Overview
  • Table 2-1: U.S. IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Three: Germany
  • Germany IVD Market Overview
  • Table 3-1: Germany IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Four: Japan
  • Japan IVD Market Overview
  • Table 4-1: Japan IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Five: China
  • China IVD Market Overview
  • Table 5-1: China IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Six: France
  • France IVD Market Overview
  • Table 6-1: France IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Seven: United Kingdom
  • United Kingdom IVD Market Overview
  • Table 7-1: United Kingdom IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Eight: Italy
  • Italy IVD Market Overview
  • Table 8-1: Italy IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Nine: Canada
  • Canada IVD Market Overview
  • Table 9-1: Canada IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Ten: Spain
  • Spain IVD Market Overview
  • Table 10-1: Spain IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Eleven: Australia
  • Australia IVD Market Overview
  • Table 11-1: Australia IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twelve: Brazil
  • Brazil IVD Market Overview
  • Table 12-1: Brazil IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Thirteen: Russia
  • Russia IVD Market Overview
  • Table 13-1: Russia IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Fourteen: India
  • India IVD Market Overview
  • Table 14-1: India IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Fifteen: Switzerland
  • Switzerland IVD Market Overview
  • Table 15-1: Switzerland IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Sixteen: Netherlands
  • Netherlands IVD Market Overview
  • Table 16-1: Netherlands IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Seventeen: Poland
  • Poland IVD Market Overview
  • Table 17-1: Poland IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Eighteen: Turkey
  • Turkey IVD Market Overview
  • Table 18-1: Turkey IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Nineteen: Sweden
  • Sweden IVD Market Overview
  • Table 19-1: Sweden IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty: Belgium
  • Belgium IVD Market Overview
  • Table 20-1: Belgium IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-One: Mexico
  • Mexico IVD Market Overview
  • Table 21-1: Mexico IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Two: Austria
  • Austria IVD Market Overview
  • Table 22-1: Austria IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Three: Saudi Arabia
  • Saudi Arabia IVD Market Overview
  • Table 23-1: Saudi Arabia IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Four: South Korea
  • South Korea IVD Market Overview
  • Table 24-1: South Korea IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Five: Romania
  • Romania IVD Market Overview
  • Table 25-1: Romania IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Six: Egypt
  • Egypt IVD Market Overview
  • Table 26-1: Egypt IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Seven: Indonesia
  • Indonesia IVD Market Overview
  • Table 27-1: Indonesia IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Eight: Chile
  • Chile IVD Market Overview
  • Table 28-1: Chile IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Twenty-Nine: South Africa
  • South Africa IVD Market Overview
  • Table 29-1: South Africa IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Thirty: United Arab Emirates
  • United Arab Emirates IVD Overview
  • Table 30-1: United Arab Emirates IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)
Chapter Thirty-One: Vietnam
  • Vietnam IVD Market Overview
  • Table 31-1: Vietnam IVD Market by Segment (Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Microbiology [with NAT & mass spec], Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose, POC Infectious Disease, POC Pregnancy & Fertility, SARS-Cov-2 [COVID-19]), 2023-2028 (in millions $)

Samples

Loading
LOADING...